PHLPP2 and pancreatic adenocarcinoma: Based on the OncoLnc database, we found the high expression of PHLPP2 was correlated with higher survival percent of patients with brain lower-grade glioma (LGG; logrank P = .00623; Figure 5) and pancreatic adenocarcinoma (PAAD; logrank P = .00109; Figure 6).